International Journal of Cancer Management

Published by: Kowsar

Factors Affecting Recurrence and Costs of Basal Cell Carcinoma Undergoing Mohs Micrographic Surgery: A Hospital-Based Retrospective Cohort Study

Leila Nassiripour ORCID 1 , Mohammadreza Amirsadri 2 , Maryam Tabatabaeian 3 and Mohammad Reza Maracy ORCID 1 , *
Authors Information
1 Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
3 Isfahan University of Medical Sciences, Isfahan, Iran
Article information
  • International Journal of Cancer Management: August 31, 2019, 12 (8); e84695
  • Published Online: August 7, 2019
  • Article Type: Research Article
  • Received: September 28, 2018
  • Revised: July 13, 2019
  • Accepted: July 16, 2019
  • DOI: 10.5812/ijcm.84695

How to Cite: Nassiripour L, Amirsadri M, Tabatabaeian M, Maracy M R. Factors Affecting Recurrence and Costs of Basal Cell Carcinoma Undergoing Mohs Micrographic Surgery: A Hospital-Based Retrospective Cohort Study, Int J Cancer Manag. 2019 ; 12(8):e84695. doi: 10.5812/ijcm.84695.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149(6):1200-6. doi: 10.1111/j.1365-2133.2003.05554.x. [PubMed: 14674897].
  • 2. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283-7. doi: 10.1001/archdermatol.2010.19. [PubMed: 20231499].
  • 3. Rigel DS, Friedman RJ, Kopf AW. Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5. J Am Acad Dermatol. 1996;35(6):1012-3. doi: 10.1016/s0190-9622(96)90139-5. [PubMed: 8959974].
  • 4. American Cancer Society. Cancer Facts & Figures. 2011. Available from:
  • 5. Nabizadeh R, Salehi S, Younesian M, Naddafi K. [Evaluation of the relationship between global ultraviolet indea in different regions of iran with skin cancer in 1383]. Iran J Health Environ. 2010;2(4):258-67. Persian.
  • 6. Jadotte YT, Sarkissian NA, Kadire H, Lambert WC. CASE REPORT Superficial Spreading Basal Cell Carcinoma of the Face: A Surgical Challenge. Eplasty. 2010;10. e46. [PubMed: 20596236]. [PubMed Central: PMC2890390].
  • 7. Abide JM, Nahai F, Bennett RG. The meaning of surgical margins. Plast Reconstr Surg. 1984;73(3):492-7. doi: 10.1097/00006534-198403000-00030. [PubMed: 6701225].
  • 8. Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: Tissue-sparing outcome. Dermatol Surg. 2009;35(9):1349-54. doi: 10.1111/j.1524-4725.2009.01240.x. [PubMed: 19500127].
  • 9. Essers BA, Dirksen CD, Nieman FH, Smeets NW, Krekels GA, Prins MH, et al. Cost-effectiveness of mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol. 2006;142(2):187-94. doi: 10.1001/archderm.142.2.187. [PubMed: 16490846].
  • 10. Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol. 2008;9(12):1149-56. doi: 10.1016/S1470-2045(08)70260-2. [PubMed: 19010733].
  • 11. van Loo E, Mosterd K, Krekels GA, Roozeboom MH, Ostertag JU, Dirksen CD, et al. Surgical excision versus Mohs' micrographic surgery for basal cell carcinoma of the face: A randomised clinical trial with 10 year follow-up. Eur J Cancer. 2014;50(17):3011-20. doi: 10.1016/j.ejca.2014.08.018. [PubMed: 25262378].
  • 12. Wennberg AM, Larko O, Stenquist B. Five-year results of Mohs' micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol. 1999;79(5):370-2. doi: 10.1080/000155599750010292. [PubMed: 10494714].
  • 13. Paoli J, Daryoni S, Wennberg AM, Molne L, Gillstedt M, Miocic M, et al. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm Venereol. 2011;91(6):689-93. doi: 10.2340/00015555-1134. [PubMed: 21681360].
  • 14. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol. 2005;53(3):452-7. doi: 10.1016/j.jaad.2005.04.087. [PubMed: 16112352].
  • 15. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature. Br J Dermatol. 2004;151(1):141-7. doi: 10.1111/j.1365-2133.2004.06047.x. [PubMed: 15270883].
  • 16. Veronese F, Farinelli P, Zavattaro E, Zuccoli R, Bonvini D, Leigheb G, et al. Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol. 2012;26(7):838-43. doi: 10.1111/j.1468-3083.2011.04165.x. [PubMed: 21707774].
  • 17. Rowe DE, Carroll RJ, CL Jr CJ. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424-31. doi: 10.1111/j.1524-4725.1989.tb03249.x. [PubMed: 2925988].
  • 18. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315-28. doi: 10.1111/j.1524-4725.1989.tb03166.x. [PubMed: 2646336].
  • 19. Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. J Am Acad Dermatol. 2005;53(3):445-51. doi: 10.1016/j.jaad.2005.04.083. [PubMed: 16112351].
  • 20. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol. 2002;147(1):41-7. doi: 10.1046/j.1365-2133.2002.04804.x. [PubMed: 12100183].
  • 21. McGovern TW, Leffell DJ. Mohs surgery: The informed view. Arch Dermatol. 1999;135(10):1255-9. doi: 10.1001/archderm.135.10.1255. [PubMed: 10522675].
  • 22. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol. 1999;135(10):1177-83. doi: 10.1001/archderm.135.10.1177. [PubMed: 10522664].
  • 23. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol. 1992;18(6):471-6. doi: 10.1111/j.1524-4725.1992.tb03307.x. [PubMed: 1592998].
  • 24. Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: Randomised controlled trial. Lancet. 2004;364(9447):1766-72. doi: 10.1016/S0140-6736(04)17399-6. [PubMed: 15541449].
  • 25. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol. 1998;39(5 Pt 1):698-703. doi: 10.1016/s0190-9622(98)70041-6. [PubMed: 9810885].
  • 26. Bialy TL, Whalen J, Veledar E, Lafreniere D, Spiro J, Chartier T, et al. Mohs micrographic surgery vs traditional surgical excision: A cost comparison analysis. Arch Dermatol. 2004;140(6):736-42. doi: 10.1001/archderm.140.6.736. [PubMed: 15210467].
  • 27. Seidler AM, Bramlette TB, Washington CV, Szeto H, Chen SC. Mohs versus traditional surgical excision for facial and auricular nonmelanoma skin cancer: An analysis of cost-effectiveness. Dermatol Surg. 2009;35(11):1776-87. doi: 10.1111/j.1524-4725.2009.01291.x. [PubMed: 19737291].
  • 28. Ravitskiy L, Brodland DG, Zitelli JA. Cost analysis: Mohs micrographic surgery. Dermatol Surg. 2012;38(4):585-94. doi: 10.1111/j.1524-4725.2012.02341.x. [PubMed: 22443180].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments